Costs of complications after allogeneic myeloablative stem cell transplantation.

被引：0
|
作者：
Saito, Akiko M.
Cutler, Corey
Zahrieh, David
Ho, Vincent T.
Alyea, Edwin P.
Soiffer, Robert J.
Antin, Joseph H.
Lee, Stephanie J.
机构：
[1] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2977.2977
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2977
引用
收藏
页码：844A / 844A
页数：1
相关论文
共 50 条
  • [1] Progressive disease after non-myeloablative allogeneic stem cell transplantation.
    Bolwell, BJ
    Pohlman, B
    Sobecks, R
    Andresen, S
    Theil, KS
    Brown, S
    Bernhard, L
    Curtis, J
    Koennecke, J
    Kosar, J
    Ostendorf, H
    Sands, K
    Serafin, M
    Kalaycio, M
    [J]. BLOOD, 2002, 100 (11) : 634A - 634A
  • [2] Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation
    Schulenburg, A
    Turetschek, K
    Wrba, F
    Vogelsang, H
    Greinix, HT
    Keil, F
    Mitterbauer, M
    Kalhs, P
    [J]. ANNALS OF HEMATOLOGY, 2004, 83 (02) : 101 - 106
  • [3] Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation
    A. Schulenburg
    K. Turetschek
    F. Wrba
    H. Vogelsang
    H. T. Greinix
    F. Keil
    M. Mitterbauer
    P. Kalhs
    [J]. Annals of Hematology, 2004, 83 : 101 - 106
  • [4] Leukemia immunotherapy in conjunction with non myeloablative allogeneic stem cell transplantation.
    Slavin, S
    Nagler, A
    Naparstek, E
    Or, R
    Varadi, G
    Ben-Yosef, R
    Hussien, A
    Aker, M
    Cividalli, G
    [J]. EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 779 - 779
  • [5] Comparison of lung function after nonmyeloablative versus myeloablative allogeneic hematopoietic stem cell transplantation.
    Chien, JW
    Maris, MB
    Parimon, T
    Sandmaier, BM
    Maloney, DG
    Storb, RF
    Clark, JG
    [J]. BLOOD, 2004, 104 (11) : 360B - 360B
  • [6] Hemorrhagic toxoplasmosis after non-myeloablative condotioning therapy and allogeneic stem cell transplantation.
    Fuchs, M
    Stenzel, W
    Scheid, C
    Sasse, S
    Holtick, U
    Diehl, V
    Waldschmidt, DT
    [J]. BLOOD, 2002, 100 (11) : 438B - 438B
  • [7] Fatal infectious complications developing late after allogeneic stem cell transplantation.
    Bjorklund, A
    Aschan, J
    Ringden, O
    Winiarski, JH
    Ljungman, PT
    [J]. BLOOD, 2005, 106 (11) : 905A - 905A
  • [8] Donor erythroid chimerism in mice after non-myeloablative allogeneic stem cell transplantation.
    Iannone, R
    Luznik, L
    Engstrom, LW
    Fuchs, EJ
    [J]. BLOOD, 1999, 94 (10) : 320B - 321B
  • [9] Low incidence of infectious complications after non-myeloablative compared with myeloablative allogeneic stem cell transplantation
    Meijer, E
    Dekker, A
    Lokhorst, H
    Petersen, E
    Nieuwenhuis, K
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S198 - S198
  • [10] Immune reconstitution after non myeloablative allogeneic hematopoietic cell transplantation.
    Bruno, B
    Omede, P
    Giaretta, F
    Rotta, M
    Cimolin, L
    Bianchi, A
    Morrone, F
    Ruggieri, M
    Boccadoro, M
    [J]. BLOOD, 2002, 100 (11) : 442B - 442B
12345